Enzalutamid Sandoz 40 mg filmom obložene tablete Хорватія - хорватська - HALMED (Agencija za lijekove i medicinske proizvode)

enzalutamid sandoz 40 mg filmom obložene tablete

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - enzalutamid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 40 mg enzalutamida.

Enzalutamid Sandoz 80 mg filmom obložene tablete Хорватія - хорватська - HALMED (Agencija za lijekove i medicinske proizvode)

enzalutamid sandoz 80 mg filmom obložene tablete

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - enzalutamid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 80 mg enzalutamida.

Xtandi Європейський Союз - хорватська - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatske neoplazme - endokrinska terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

XTANDI™ 40mg Kapsula, meka Чорногорія - хорватська - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

xtandi™ 40mg kapsula, meka

druŠtvo sa ograniČenom odgovornoŠĆu "inmed" podgorica - enzalutamid - kapsula, meka - 40mg

Ztalmy Європейський Союз - хорватська - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - drugi antiepileptici sredstva - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.